MC
BMY icon

Miramar Capital’s Bristol-Myers Squibb BMY Stock Holding History

Miramar Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
216,049
+1,311
+0.6% +$75.3K 2.74% 23
2026
Q1 		$13M Sell
214,738
-5,005
-2% -$292K 2.9% 19
2025
Q4 		$11.9M Buy
219,743
+1,518
+0.7% +$73K 2.59% 22
2025
Q3 		$9.84M Sell
218,225
-1,196
-0.5% -$55.9K 2.18% 25
2025
Q2 		$10.2M Buy
219,421
+5,302
+2% +$260K 2.4% 24
2025
Q1 		$13.1M Buy
214,119
+35,858
+20% +$2.09M 3.11% 14
2024
Q4 		$10.1M Buy
178,261
+169,385
+1,908% +$9.46M 2.4% 22
2024
Q3 		$459K Hold
8,876
– – 0.11% 46
2024
Q2 		$369K Buy
8,876
+2,600
+41% +$116K 0.09% 50
2024
Q1 		$276K Hold
6,276
– – 0.07% 51
2023
Q4 		$322K Sell
6,276
-1,900
-23% -$99.7K 0.08% 48
2023
Q3 		$475K Sell
8,176
-1,794
-18% -$110K 0.13% 44
2023
Q2 		$638K Sell
9,970
-1,103
-10% -$74K 0.16% 40
2023
Q1 		$767K Hold
11,073
– – 0.2% 40
2022
Q4 		$797K Sell
11,073
-200
-2% -$15.1K 0.21% 46
2022
Q3 		$899K Sell
11,273
-518
-4% -$37.6K 0.25% 44
2022
Q2 		$908K Buy
11,791
+334
+3% +$25.4K 0.26% 42
2022
Q1 		$837K Buy
+11,457
New +$769K 0.23% 54
2020
Q1 		– Sell
-4,239
Closed -$273K – 44
2019
Q4 		$273K Buy
+4,239
New +$243K 0.17% 46

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Miramar Capital's BMY Position: Q2 2026 in Review

Miramar Capital increased its Bristol-Myers Squibb (BMY) stake by 0.61% in Q2 2026, buying an estimated $75.3K and bringing the position to 216,049 shares worth $12.4M. The position accounts for 2.74% of the portfolio, ranked #23.

Miramar Capital first reported a position in BMY in Q4 2019 and has held it in 19 quarters since. The position peaked at $13.1M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Miramar Capital held 216,049 shares of Bristol-Myers Squibb worth $12.4M as of Q2 2026.
  • Miramar Capital bought 1,311 Bristol-Myers Squibb shares in Q2 2026, an estimated $75.3K.
  • Bristol-Myers Squibb made up 2.74% of Miramar Capital's portfolio in Q2 2026, its #23 holding.
  • Miramar Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 19 quarters since.
  • Miramar Capital's Bristol-Myers Squibb position peaked at $13.1M in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Miramar Capital's 13F filing for Q2 2026, filed 27 Jul 2026.